Fresh from Pfizer deal, Roivant posts 'best-in-class' ulcerative colitis data on rival to Prometheus prospect
https://www.fiercebiotech.com/biotech/fresh-pfizer-deal-roivant-posts-best-class-ulcerative-colitis-data-and-stokes-prometheus
Medical Innovation Exchange @ Copywrite 2021. All Rights Reserved.